Autophagy in adipogenesis: Molecular mechanisms and regulation by bioactive compounds

• Published in: Biomedicine & pharmacotherapy 2022-11, Vol.155, p.113715-113715, Article 113715
• Main Authors: Khan, Faizullah, Khan, Haroon, Khan, Ajmal, Yamasaki, Masao, Moustaid-Moussa, Naima, Al-Harrasi, Ahmed, Rahman, Shaikh Mizanoor
• Format: Article
• Language: English
• Subjects: Adipogenesis; Autophagy; Bioactive compounds; Molecular regulation; Transcription factor
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2022.113715

White adipose tissue expands rapidly due to increased adipocyte number (hyperplasia) and size (hypertrophy), which results in obesity. Adipogenesis is a process of the formation of mature adipocytes from precursor cells. Additionally, obesity-related metabolic complications, such as fatty liver and insulin resistance, are linked to adipogenesis. On the contrary, autophagy is a catabolic process; essential to maintain cellular homeostasis via the degradation or recycling of unnecessary or damaged components. Importantly, autophagy dictates obesity and adipogenesis. Hence, a clear understanding of how autophagy regulates adipogenesis is crucial for drug development and the prevention and treatment of obesity and its associated disorders, such as type 2 diabetes, cardiovascular disease, and cancer. In this review, we highlighted recent findings regarding the crosstalk between adipogenesis and autophagy, as well as the molecules involved. Furthermore, the review discussed how bioactive compounds regulate adipogenesis by manipulating autophagy and underlying molecular mechanisms. Based on in vitro and animal studies, we summarized the effects of bioactive compounds on adipogenesis and autophagy. Hence, human studies are necessary to validate the effectiveness and optimal dosage of these bioactive compounds.